Hillman Capital Management, Inc. Amgen Inc Transaction History

Hillman Capital Management, Inc.

  • $283 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 04, 2020
SELL
$197.81 - $242.74 $1.76 Million - $2.16 Million
-8,888 Closed
0 $0
Q1 2020

Apr 29, 2020
SELL
$182.24 - $241.7 $48,111 - $63,808
-264 Reduced 2.88%
8,888 $1.8 Million
Q4 2019

Feb 14, 2020
BUY
$189.21 - $243.2 $1.73 Million - $2.23 Million
9,152 New
9,152 $2.21 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hillman Capital Management, Inc. Portfolio

Follow Hillman Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillman Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email